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The terminal t-loop structure adopted by
mammalian telomeres is thought to prevent
telomeres from being recognized as double-
stranded DNA breaks by sequestering the 30
single-strandedG-rich overhang from exposure
to the DNA damage machinery. The POT1 (pro-
tection of telomeres) protein binds the single-
stranded overhang and is required for both
chromosomal end protection and telomere
length regulation. The mouse genome contains
two POT1 orthologs, Pot1a and Pot1b. Here we
show that conditional deletion of Pot1a elicits a
DNA damage response at telomeres, resulting
in p53-dependent replicative senescence.
Pot1a-deficient cells exhibit overall telomere
length and 30 overhang elongation as well as ab-
errant homologous recombination (HR) at telo-
meres, manifested as increased telomere sister
chromatid exchangesand formation of telomere
circles. Telomeric HR following Pot1a loss re-
quiresNBS1.Pot1adeletion also results in chro-
mosomal instability. Our results suggest that
POT1a is crucial for the maintenance of both
telomere integrity and overall genomic stability.
INTRODUCTION
Telomeres are nucleoprotein structures that cap the ends
of eukaryotic chromosomes and play crucial roles in en-
suring genomic stability by providing both end protection
and a mechanism for maintenance of chromosomal ends.
In mammals, telomeres consist of TTAGGG repetitivesequences that terminate in a 30 single-stranded G-rich
overhang. Telomeres can fold into a structure termed
the t-loop, in which the 30 single-stranded overhang in-
vades a duplex region of the telomere to sequester the
overhang (Griffith et al., 1999; Murti and Prescott, 1999).
This ‘‘closed’’ telomeric conformation most likely serves
to protect natural DNA ends from being recognized as
double-strand breaks (DSBs) that would otherwise acti-
vate DNA damage checkpoint responses or participate
in aberrant recombination events (de Lange, 2005). How-
ever, an ‘‘open’’ telomeric conformation must also exist
to facilitate replication of telomeres during S phase. Telo-
meres are maintained by the enzyme telomerase, which is
limiting in human somatic cells, resulting in progressive
telomere shortening because conventional DNA polymer-
ases cannot fully replicate the extreme terminus of the lag-
ging DNA strand (Blackburn, 2001). Therefore, telomere
attrition occurs with each round of DNA replication, and,
eventually, critically shortened, dysfunctional telomeres
are generated that engage canonical DNA damage re-
sponse pathways to initiate the onset of replicative senes-
cence (Maser and DePinho, 2004).
The t-loop is bound and stabilized by a number of telo-
mere-specific binding proteins that form a complex,
termed the telosome (Liu et al., 2004b) or shelterin (de
Lange, 2005). Three sequence-specific DNA binding pro-
teins are recruited to chromosomal ends: the duplex telo-
mere binding proteins TRF1 and TRF2 and the single-
stranded TTAGGG repeat binding protein POT1. TRF1 is
a negative regulator of telomere length since its overex-
pression results in telomere attrition (van Steensel and
de Lange, 1997). TRF1 forms a complex with several pro-
teins, including tankyrase, TIN2, TPP1, and POT1 (Loayza
and de Lange, 2003; Houghtaling et al., 2004; Liu et al.,
2004b; Ye et al., 2004b). Deletion of TRF2 results in telo-
mere uncapping and chromosomal end-to-end fusions,
indicating that it is essential for telomere end protectionCell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc. 49
(Celli and de Lange, 2005). TRF2 also complexes with a
number of proteins, including Rap1, TIN2, and POT1
(Li et al., 2000; Houghtaling et al., 2004; Kim et al., 2004;
Liu et al., 2004b; Ye et al., 2004b; Yang et al., 2005). Recent
evidence suggests that the TRF1 and TRF2 complexes
interact with each other to regulate telomere dynamics
(Kim et al., 2004; Liu et al., 2004b; Ye et al., 2004b), and
this functional connection may be mediated through
POT1. POT1 was originally discovered in S. pombe (Bau-
mann and Cech, 2001), and POT1 homologs have been
identified in a large variety of eukaryotes, including plant
(Shakirov et al., 2005), chicken (Wei and Price, 2004),
and human (Baumann et al., 2002; Loayza and de Lange,
2003). All POT1 homologs identified to date contain two
highly conserved oligonucleotide/oligosaccharide binding
folds (OB folds) that bind to the 30 terminus of the G-rich
telomeric overhang (Baumann and Cech, 2001; Baumann
et al., 2002; Loayza and de Lange, 2003; Wei and Price,
2004). Structural studies indicate that both OB folds inter-
act with single-stranded telomeric DNA with high affinity:
The first OB fold interacts with the first six nucleotides of
the telomeric repeat, while the second binds and protects
the terminal 30 end of telomeric DNA (Lei et al., 2003, 2004).
In accord with its end-protective function, deletion of pot1
in yeast results in catastrophic loss of telomeric DNA and
chromosomal end-to-end fusions, leading to rapid death
(Baumann and Cech, 2001). Survivors emerge with circu-
larized chromosomes, obviating the need for the telomeric
protective function of POT1. In addition, siRNA knock-
down of POT1 leads to a DNA damage response at telo-
meres, cytogenetic aberrations including anaphase bridge
formation, and cell death (Hockemeyer et al., 2005; Veld-
man et al., 2004; Yang et al., 2005). These results indicate
that POT1 is an integral telomere end-protection protein
and that loss of POT1 results in dysfunctional telomeres
that are targeted for end-joining reactions.
Mounting evidence suggests that POT1 also plays an
important role in telomere length regulation. POT1 is re-
cruited to telomeres through its interaction with TPP1,
and both proteins form a complex with TRF1 (Houghtaling
et al., 2004; Liu et al., 2004a; Ye et al., 2004a). Consistent
with its function as a negative regulator of telomere length,
reduction of endogenous POT1 levels by siRNA knock-
down (Liu et al., 2004a; Ye et al., 2004a) or overexpression
of the Pot1 DOB mutant (Loayza and de Lange, 2003) re-
sults in telomere elongation. In addition, biochemical anal-
yses using purified POT1 and telomerase demonstrated
that POT1 negatively regulates telomerase activity in vitro
by limiting its access to the terminal G residue of telo-
meres (Kelleher et al., 2005; Lei et al., 2005). These results
are particularly interesting in light of a recent report sug-
gesting that telomeres exist in extendable and nonextend-
able states and that telomerase acts preferentially on the
shortest telomeres (Teixeira et al., 2004). It is possible
that the affinity of POT1 to the 30 single-stranded overhang
mediates control between these two telomeric states.
POT1 can negatively regulate telomere length by inhibit-
ing telomerase access to long telomeric substrates or50 Cell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc.promote telomere extension by enabling telomerase to ac-
cess short telomeric ends. Since disruption of the TRF1
complex also results in telomere elongation (reviewed in
Smogorzewska and de Lange, 2004), these data are con-
sistent with a model in which TRF1 is the sensor of telo-
mere length, and this length information is relayed to
POT1 to regulate telomerase access to the 30 telomeric
terminus (Loayza and de Lange, 2003).
One major unresolved question is how shelterin/telo-
some protects chromosomal ends from initiating aberrant
recombination reactions, since t-loops resemble Holliday
junctions, structures characteristic of substrates undergo-
ing homologous recombination (HR). The mouse genome
contains two POT1 orthologs, Pot1a and Pot1b. Here, us-
ing mice with a conditional allele of Pot1a, we show that
POT1a plays a major role in repressing recombination at
telomeres. Conditional deletion of Pot1a leads to telomere
deprotection, eliciting a DNA damage response that initi-
ates replicative senescence in a p53-dependent manner.
Aberrant cytogenetic products following Pot1a deletion
suggest that POT1a normally suppresses both nonhomol-
ogous end-joining (NHEJ) and HR at telomeres. Finally,
Pot1a deletion results in chromosomal instability, en-
hanced cellular transformation, and tumor formation in
a p53-deficient background. Our results suggest that
POT1a is crucial not only for the maintenance of telomere
integrity but also for overall genomic stability and suppres-
sion of tumorigenesis.
RESULTS
Cloning and Sequence Analysis of Mouse Pot1a
While the human genome contains only one POT1 gene
(Baumann and Cech, 2001), we identified two putative
mouse Pot1 orthologs using the S. pombe Pot1 protein
sequence as the query in a BLAST search of the M. mus-
culus genome database (Baumann and Cech, 2001). A
PCR-based strategy was used to clone both genes,
termed Pot1a and Pot1b. Pot1a encodes a protein 641
amino acids in length and is located on mouse chromo-
some 6, while Pot1b is located on mouse chromosome
17 (H.H, A.S.M., W.C.-B., H.T., J. Ma, S.P., Y.D., and
S.C. unpublished data; Hockemeyer et al., 2006 [this issue
of Cell]). Both genes are highly homologous to the human
ortholog (see Figure S1A in the Supplemental Data avail-
able with this article online). Here we focus our efforts on
the characterization of Pot1a. POT1a possesses two OB
folds: OB1 is 81% identical and 89% similar to the corre-
sponding region in POT1, while OB2 is 75% identical and
82% similar. In addition, the C-terminal portion of POT1a
is 70% identical to the C terminus of POT1. RT-PCR anal-
ysis of Pot1a expression revealed that it is detected in
early embryonic stages and in all adult tissues examined
(Figure S1B).
Characterization of Biological Properties of POT1a
Biochemical and structural analyses revealed that the
POT1 OB folds are critical for telomere binding. To test
Figure 1. Characterization of Biological Properties of Murine POT1a
(A) The Pot1a mutants generated are shown schematically. Dot indicates site of point mutation.
(B) Electrophoretic mobility shift assay of 32P-labeled oligonucleotide in the presence of in vitro-translated POT1a proteins.
(C) Colocalization of myc-tagged POT1a constructs with TRF1 in MEFs.
(D) CoIP pulldown andWestern analysis were performed onMEFs transfectedwith DNA constructs (left) using the indicated antibodies.Western blots
with anti-myc and anti-HA antibodies were used to quantitate protein expression levels.which amino acid residues within the POT1a OB folds are
involved in binding to single-strand telomeric DNA, we
generated a series of 30 myc-tagged cDNA constructs en-
coding either full-length (FL) POT1a or N-terminal POT1a
containing the first 341 amino acids. These constructs en-
codedwild-type OB folds, mutants possessing large dele-
tions (DOB1a, 132 aa deletion; DOB1b, 49 aa deletion), or
specific point mutations within OB1 that are predicted to
disrupt DNA binding (Figure 1A; Lei et al., 2003, 2004).
Constructs were translated in vitro, and electrophoretic
mobility shift assays performed with a radiolabeled telo-
meric oligo confirmed that all POT1a proteins containing
the wild-type OB folds efficiently bound single-stranded
(ss) telomeric DNA to form protein-DNA complexes (Fig-
ure 1B). In contrast, both DOB1 mutants failed to bind ss
telomeric DNA (Figure 1B). Structural analysis of yeast
and human POT1 proteins revealed that phenylalanine at
position 62 may be critically important for telomere bind-
ing (Lei et al., 2003, 2004); this was confirmed since theF62A substitution abolished complex formation with ss
telomeric DNA (Figure 1B). Taken together, these results
support the observation that the first POT1aOB fold is crit-
ically important for binding to ss telomeric DNA.
To determine whether POT1a localizes to mammalian
telomeres in vivo, myc-tagged full-length POT1awas tran-
siently expressed in mouse embryonic fibroblasts (MEFs).
Indirect immunofluorescence yielded a punctate staining
pattern that colocalized with the telomere binding protein
TRF1, indicating that POT1a is present at telomeres
(Figure 1C). In contrast to N-terminal POT1a, full-length
POT1a containing the F62A mutation and both DOB1
mutants localized to telomeres, reinforcing the notion
that the OB fold is not required for POT1a localization
to telomeres in vivo (Loayza and de Lange, 2003). Recent
reports suggest that the TPP1 protein interacts with the
C terminus of POT1 to recruit it to telomeres (Houghtal-
ing et al., 2004; Liu et al., 2004a; Ye et al., 2004a). To in-
vestigate whether POT1a interacts with TPP1, we clonedCell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc. 51
Figure 2. Conditional Deletion of Mouse Pot1a
(A) Schematic depicting the conditional Pot1a knockout construct, showing exons 4 and 5 (red boxes) flanked by loxP sites (arrowheads), the neo-
mycin gene (green rectangle) flanked by frt sites (slanted bars), and the diphtheria toxin (DT) negative selection marker (yellow). Also shown are the
Pot1a locus, the recombined (Pot1arec) allele, and the null (Pot1aD) allele. The DNA probes used for Southern analyses are indicated. S, StuI; B, BglI.
(B) Correct targeting into ES cells is expected to yield two fragments 9.1 and 7 kb in size after BglI digestion and was detected with a 50 probe.
(C) Genomic PCR of Pot1a from DNAs isolated from AdE- and AdCre-treated (moi = 100) Pot1arec/D MEFs.
(D) RT-PCR of Pot1a from total RNAs isolated from AdE- and AdCre-treated Pot1arec/D MEFs. GAPDH is included as a loading control.
(E) Western blot analysis of AdE- and AdCre-infected Pot1arec/DMEFs using a chicken anti-mouse POT1a antibody. *: nonspecific band used as load-
ing control.mouse Tpp1, tagged it with the hemagglutinin (HA) epi-
tope, and used it in coimmunoprecipitation experiments
with myc-tagged Pot1a constructs. FL wild-type, FL
F62A, and FL DOB1a POT1a proteins readily bound to
TPP1, while N-terminal POT1a did not (Figure 1D). In ad-
dition, direct interaction between POT1a and TPP1 was
detected with a yeast two-hybrid system (Table S1).
Taken together, these results suggest that the C termi-
nus of POT1a is required for TPP1-mediated localization
to telomeres in vivo.
Generation of Conditional Pot1a Knockout Mice to
Assess Loss of Pot1a Function
Because homozygous deletion of Pot1a results in early
embryonic death (data not shown), we utilized a condi-
tional knockout approach to address the function of
POT1a at telomeres. The Pot1a gene encodes 19 exons,52 Cell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc.with exon 4 containing the translation initiation site and
exon 5 containing a portion of OB1 critically important
for telomere binding (Baumann et al., 2002).We generated
a conditional Pot1a knockout construct in which both
exons 4 and 5 are flanked by loxP sites, enabling condi-
tional inactivation of this allele (Figure 2A). Electroporation
of this construct into ES cells and selecting for G418-resis-
tant clones yielded three correctly recombined (rec) ES
cell lines (Figure 2B). Two Pot1arec/+ ES cell lines were in-
jected into blastocysts to generate chimeric mice, and
crosses between chimeric mice and C57BL/6 animals
produced Pot1arec/+ mice. Breeding Pot1arec/+ mice with
CMV-Cre mice resulted in deletion of exons 4 and 5 in
the recombined allele, generating Pot1aD/+ animals
(Figure 2A). Pot1aD/+ 3 Pot1aD/+ mice failed to generate
any Pot1aD/D offspring or E13.5 embryos, suggesting
that this genotype results in embryonic lethality (data not
shown). We established Pot1arec/+ 3 Pot1aD/+ cohorts to
generate MEFs for subsequent experiments.
Deletion of Pot1a Promotes the Onset of p53-
Dependent Replicative Senescence
To assess the effect of Pot1a loss on cellular proliferation,
we generated wild-type, Pot1arec/+, and Pot1arec/DMEFs.
Conversion of the Pot1arec/D allele to the Pot1aD/D allele
was achieved by two methods: either by direct infection
with adenovirus expressing Cre (AdCre) or by generating
stable cell lines with pBabe-CreER and activating the
Cre recombinase with exogenously administered tamoxi-
fen (Hayashi and McMahon, 2002; data not shown). Both
Cre delivery methods generated similar results. Genomic
PCR indicated that the Pot1a gene was efficiently deleted
within 48 hr following AdCre expression in Pot1arec/D
MEFs (Figure 2C). While our targeting strategy was de-
signed to abolish Pot1a transcription and result in an
out-of-frame shift of downstream Pot1a exons, given the
numerous cryptic translation start sites present within
the Pot1a genome, it is possible that a truncated version
of Pot1a possessing dominant-negative effects could re-
sult from this approach. RT-PCR of mRNA isolated from
Pot1aD/D MEFs did not detect transcripts encoding trun-
cated Pot1a (Figure 2D and data not shown). We also
did not detect any truncated forms of the POT1a protein
by immunoblotting with antisera raised against a Pot1a
peptide (amino acids 296–347 of exon 10; Figure 2E).
Following AdCre administration, cellular proliferation
was markedly compromised in Pot1arec/D MEFs, while lit-
tle effect on growthwas observed in AdE-treatedPot1arec/D
MEFs (Figure 3A). The decline in proliferative capacity fol-
lowing Pot1a deletion correlated with an 11-fold increase
in the number of senescence-associated (SA) b-galactosi-
dase-positive cells (Figures 3B and 3C) and an4-fold de-
cline in the number of BrdU-positive cells (Figure 3D).
Overexpression of full-length Pot1a construct in Pot1aD/D
cells was able to partially rescue this senescence pheno-
type (Figure S2A). Consistent with the observation that
cells undergoing replicative senescence activate the
p53-dependent DNA damage pathway, deletion of Pot1a
results in phosphorylation of p53 serine 15 (Banin et al.,
1998; Canman et al., 1998) and upregulation of p21
(Figure 3E). Further evidence that the senescence-like
growth arrest following Pot1a loss was dependent upon
p53 stems from observations that cellular growth was no
longer compromised inPot1aD/D, p53/MEFs (Figure3F).
Taken together, these results suggest that, in the setting
of intact p53, loss of Pot1a leads to a senescence pheno-
type indistinguishable from replicative senescence.
Elevated DNA Damage Response in Pot1aD/D MEFs
Dysfunctional telomeres activate the DNA damage path-
way, resulting in replicative senescence (Karlseder et al.,
1999; d’Adda di Fagagna et al., 2003; Takai et al., 2003;
Celli and de Lange, 2005). The induction of p53 phosphor-
ylation and the ability of p53 deficiency to rescue the resul-
tant senescence phenotype observed in Pot1aD/D MEFsprompted us to examine whether a DNA damage re-
sponse at telomeres is activated following Pot1a deletion.
As early as 24 hr following AdCre treatment, 31%and 24%
of the Pot1aD/D, p53+/+ cells contained at least four
gH2AX- and 53BP1-positive foci, respectively, while
Pot1aD/+, p53+/+ or Pot1arec/D, p53+/+ MEFs were only
minimally positive for these markers of DNA damage (Fig-
ures 4A and 4B). To ascertain whether the DNA damage
response originated at telomeres, we utilized the telo-
mere-dysfunction-induced foci (TIF) assay, which moni-
tors the telomeric association of DNA damage proteins
gH2AX and 53BP1 (Takai et al., 2003). Ninety-six hours
after AdCre treatment,50% of Pot1aD/D, p53+/+ cells ex-
hibited at least six TIFs, suggesting a robust induction of
the DNA damage response at telomeres following Pot1a
deletion. (Figure 4C; Figure S3A). TIF formation was ac-
companied by the accumulation of other DNA damage
markers, including ATM phospho-Ser1981 and phos-
pho-Chk2 (Figure 4D). The activation of a DNA damage
response by Pot1a deletion did not stimulate the p53-
dependent apoptotic pathway, as evidenced by a lack of
TUNEL staining in Pot1aD/D, p53+/+ MEFs (Figure S3C).
Recent observations suggest that release of POT1 from
telomeres in the G2 phase of the cell cycle results in tran-
sient telomere deprotection (Verdun et al., 2005). The in-
creased number of TIFs observed followingPot1a deletion
suggests that Pot1aD/D telomeres can no longer form
a protective structure to shield chromosome termini
from DNA damage. To examine this possibility, a terminal
deoxytransferase (TdT) assay that adds FITC-conjugated
deoxyuridine to naked telomere ends (Verdun et al., 2005)
was used to probe telomeric structure in unsynchronized
Pot1aD/D, p53+/+ MEFs. The TdT-FITC assay did not de-
tect specific nuclear staining in untreated Pot1arec/D,
p53+/+ controls (Figure 4F). In contrast, 83% of TdT sig-
nals colocalized with telomeres in 73%ofPot1aD/D, p53+/+
cells examined (Figures 4E and 4F). Taken together, these
results reinforce the notion that loss of Pot1a results in
telomere deprotection, exposing chromosomal termini to
the DNA damage pathway that leads to the onset of
p53-dependent replicative senescence.
Altered Telomere Length Homeostasis
in Pot1a-Deficient MEFs
POT1 negatively regulates telomere length by limiting tel-
omerase access to telomeres (Kelleher et al., 2005). This
result was further substantiated by the observation that
deletion of Pot1a resulted in telomere elongation, as re-
vealed by quantitative telomere PNA-FISH (Figure 5A),
a telomere-specific hybridization protection assay (Fig-
ure 5B; Tahara et al., 2005) and TRF Southern analysis
(Figure 5C). Global telomere elongation was accompanied
by a reduction in the number of very short telomeres over
the time course examined (Figure 5A). Unexpectedly, we
also observed an approximately 2-fold increase in overall
G strand overhang length following Pot1a deletion (Fig-
ures 5B and 5C). This overhang length increase was spe-
cific to Pot1a loss since it was observed only in Pot1aD/DCell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc. 53
Figure 3. Premature Senescence in Primary Mouse Fibroblasts following Pot1a Deletion
(A) Growth curve of Pot1arec/D, p53+/+ and Pot1arec/+, p53+/+MEFs treated with vector (AdE) or Cre recombinase (AdCre), as indicated, each at a moi
of 100. In this and all other figures, error bars represent standard error of the mean (SEM).
(B) Prominent senescence-associated (SA) b-gal staining is observed only in AdCre-treated Pot1arec/D p53+/+ MEFs.
(C) Quantitation of SA b-gal-positive cells per high-power field (HPF). p value was calculated by Student’s t test.
(D) BrdU incorporation of Pot1arec/+, p53+/+ and Pot1arec/D, p53+/+ MEFs at 0, 4, and 6 days after treatment with AdE or AdCre. Percentage of BrdU-
positive cells is indicated.
(E) Immunoblots of lysates fromPot1arec/D, p53+/+ andPot1arec/+, p53+/+MEFs. Cells were treated with AdE () or AdCre (+). Ten grays g-IR (+) served
as positive control. Blots were probed for p53-phospho-Ser15 and p21 levels. Tubulin served as a loading control.
(F) Growth curve of Pot1arec/D, p53/ MEFs untreated (UT) or treated with AdE or AdCre at a moi of 100.MEFs (Figures 5B and 5C). The G strand overhang dimin-
ished following treatment with exonuclease I, demonstrat-
ing that the single-strandedG-rich repeats originated from
the 30 end of telomeres. The 30 overhang appears to be
partially resistant to exonuclease I digestion after Pot1a
loss, even when the exonuclease was present in excess
(Figures 5B and 5C and data not shown). Since POT1 con-
trols the nucleolytic processing of the 50 C-rich strand
(Hockemeyer et al., 2005), it is possible that loss of the
POT1a protective cap could stimulate unregulated C
strand processing by a 50 exonuclease (or exonucleases),
resulting in overhang elongation.
Despite the overall increase in the length of the G over-
hang, visualization of both leading and lagging telomeres
by dual-label chromosome orientation FISH (CO-FISH)54 Cell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc.on the same metaphase spreads revealed a 6-fold in-
crease in lagging-strand telomere loss in approximately
3% of Pot1aD/D, p53/ chromosomes examined (Fig-
ure 5D and Table S2). In contrast, lagging-strand telo-
meres were not preferentially lost in Pot1arec/D, p53/
controls. Loss of lagging-strand telomeres in Pot1aD/D
MEFs is consistent with POT1’s proposed role in protect-
ing the 30 single-stranded G-rich overhang from nucleo-
lytic degradation (Baumann and Cech, 2001).
Deletion of Pot1a Resulted in Aberrant Homologous
Recombination at Telomeres
Telomere FISH detected extrachromosomal telomeric
signals in the metaphase spreads of all AdCre-treated
Pot1arec/D, p53/ MEF lines at a frequency of 2.9 per
Figure 4. Elevated DNA Damage Response in Pot1a-Deleted Cells
(A) MEFs of the indicated genotypes were subjected to immunofluorescence with an antibody to gH2AX. Ten grays g-IR-treated Pot1arec/D MEFs
served as positive control.
(B) Quantitation of gH2AX and 53BP1 foci after Pot1a loss. *p < 0.01, **p < 0.001 (Student’s t test).
(C) Colocalization of DNA damage response foci to telomeres in Pot1aD/D, p53/MEFs 96 hr after AdCre treatment (moi = 100). 53BP1 was detected
with anti-53BP1 antibody (FITC, green), and telomeres were detected by telomere PNA-FISH (TRITC, red).
(D) Immunoblots detecting the level of gH2AX as well as the phosphorylation status of ATM and Chk2 in Pot1arec/D and Pot1arec/+ MEFs treated with
either AdE () or AdCre (+), each at a moi of 100. g-IR: 10 Gy g-IR.
(E) Colocalization of telomeres by telomere PNA-FISH (TRITC, red, left) and TdT-FITC (green, middle) in Pot1arec/D, p53 +/+ MEFs treated with AdCre
(moi = 100) for 4 days. Merged image is shown on right.
(F) Quantitation of colocalization of TdT-FITC signal with telomeres in Pot1arec/D, p53+/+ and Pot1aD/D, p53+/+ MEFs.metaphase (see below and Table S3). These structures
possess two telomeric signals that were of similar intensity
to telomeres at the ends of chromosomes and resemble
telomeric DNA-containing double-minute chromosomes
(TDMs), structures proposed to result from aberrant HR
events between telomeric sequences and chromosome-
internal telomeric repeats (Zhu et al., 2003; Laud et al.,
2005). TDMs were minimal in AdCre-treated Pot1aD/+,
p53/ MEFs or AdE-treated Pot1arec/D, p53/ MEFs
(Table S3), raising the possibility that deletion of Pot1a
may facilitate aberrant telomeric recombination. To further
assess whether telomere-telomere recombination is ele-
vated in Pot1aD/D, p53/ MEFs, we utilized CO-FISH to
assess the frequency of HR between telomeres of sister
chromatids (telomere sister chromatid exchanges,
T-SCEs) (Bailey et al., 2001). CO-FISH typically yieldsa characteristic pattern of two telomere signals, one on
each end of the chromosome marking either lagging or
leading strands, depending on the probe used for hybrid-
ization. However, a T-SCE eventwithin telomeric DNA splits
the probe hybridization signal between the sister chroma-
tids, creating a three- or four-telomere hybridization pattern
of signals that are often of unequal intensity. T-SCEs were
rare in AdCre-treated Pot1arec/+, p53/ and AdE-treated
Pot1arec/D, p53/ MEF controls (Figures 6A and 6B).
However, AdCre-treated Pot1arec/D, p53/ MEFs ex-
hibited a 4-fold increase (p < 0.01) in both leading- and
lagging-strand T-SCE over controls (Figures 6A and 6B),
suggesting that POT1a normally functions to suppress
T-SCE. Elevated recombination was specific to telomeric
DNAs since only background levels of genomic SCE were
observed in Pot1aD/D, p53/ MEFs (data not shown).Cell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc. 55
Figure 5. Aberrant Telomere Length Homeostasis in Pot1a-Deficient MEFs
(A) Quantitative telomere-FISH of metaphase spreads at the indicated times after Cre treatment. Mean telomere fluorescence units (TFUs) are indi-
cated, as well as the number of chromosome ends sampled. Arrows indicate signal-free telomeric ends.
(B) Hybridization protection assay (HPA) was performed on genomic DNA isolated from Pot1arec/D, p53+/+MEFs untreated (UT) or treated with AdE or
AdCre for 100 hr (moi = 100) to assess the length of G overhang and total telomere length. ExoI nuclease digestion was used to assess integrity of the
30 overhang. Luminescence intensity in arbitrary units (AU) was normalized against mouse repetitive DNA A1a.
(C) Telomere G overhang (left) and telomere length (right) assays. Pot1arec/D, p53/MEFs were treated with AdCre (moi = 100) as indicated for 48 hr,
and in-gel hybridization was performed as described (Hemann and Greider, 1999).
(D) CO-FISH revealed preferential deletion of lagging telomere DNA after Pot1a loss. Red signal: Tam-OO-(CCCTAA)4 probe; green signal: FITC-OO-
(TTAGGG)4 probe.Disruption of TRF2 can induce aberrant HR at the base
of t-loops, resulting in sudden telomere truncations and
the formation of telomeric circles (Wang et al., 2004).
The increased frequency of T-SCE and elevated lagging-
strand telomere loss observed following Pot1a deletion
prompted us to examine whether loss of Pot1a results in
t-loop HR. Fractionation of AdCre-treated Pot1arec/D,
p53/ MEF DNA by neutral-neutral 2D gel electrophore-
sis (which separates telomeric restriction fragments by
both size and shape) revealed a prominent arc of telomeric
DNA that comigrated with circularized l X HindIII DNA
fragments, consistent with relaxed, double-stranded telo-
mere circles (Figure 6C) (Wang et al., 2004). Telomeric cir-
cles formed following Pot1a deletion ranged in size from
1.5 to 60 kb, reflecting the range of telomere lengths56 Cell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc.in mouse cells and consistent with deletion of t-loops
from individual telomeres. Overexpression of full-length
Pot1a construct was able to partially reduce the formation
of telomeric circles (Figure S2B). AdE-treated Pot1arec/D,
p53/ and AdCre-treated Pot1arec/+, p53/ control
MEFs exhibited only minimal amounts of telomeric circles
(Figure 6C and data not shown), suggesting that POT1a is
normally required to repress t-loop HR.
Recent data implicate NBS1, a component of the
MRE11/RAD50/NBS1 (MRN) complex, as an effector of
t-loop HR (Wang et al., 2004). To determine whether
NBS1 is required for t-loop HR following Pot1a deletion,
we used a siRNA approach to efficiently knock down
Nbs1 expression in Pot1arec/D, p53/MEFs and then de-
lete Pot1a in these cells by AdCre expression (Figure 6D).
Figure 6. Deletion of Pot1a Results in Aberrant Homologous Recombination at Telomeres
(A) CO-FISH revealed elevated T-SCE in Pot1aD/D MEFs (arrows). Telomeres are labeled with Tam-OO-(CCCTAA)4 PNA probe (red) to detect the
lagging strand or FITC-OO-(TTAGGG)4 probe (green) to detect the leading strand.
(B) Quantitation of T-SCE in p53/ MEFs of the indicated genotypes. *p < 0.01 (Student’s t test).
(Ca–Cd) Telomeric circles are prominent in Pot1aD/D, p53/ MEFs.
(Ca) Schematic of the migration of linear and relaxed dsDNA circles.
(Cb–Cd) DNA derived from Pot1arec/D, p53/ (Cc) and Pot1aD/D, p53/ (Cb and Cd) MEFs were separated by size (1D) and shape (2D) and probed
for telomeric DNA. V: circularized l X HindIII DNAs comigrate with telomeric circles. Arrows indicate arc of telomeric circles. MW markers are in kb.
Endogenous POT1a was deleted by the addition of AdCre (moi = 100) for 96 hr.
(D) Functional NBS1 is required for formation of telomeric circles. Left panel: NBS1 levels in Pot1arec/D, p53/ MEFs were knocked down by NBS1
siRNA. Right panels: NBS1 siRNA treatment abrogated telomeric circles in Pot1aD/D, p53/ MEFs (Dc) but not in control cells (Da and Db).Reduction of NBS1 completely abrogated t-loop HR in
Pot1aD/D, p53/ MEFs (Figure 6D). In contrast, t-loop
HR was prominent in vector-treated Pot1arec/D, p53/
MEFs. These results suggest that NBS1 is required for
t-loop HR following Pot1a deletion.
Loss of POT1a Promotes Chromosomal Aberrations
To examine the effect of POT1a on telomere protection,
multiple independent lines of early-passage Pot1arec/D,
p53/ and Pot1arec/+, p53/ MEFs were generated for
cytogenetic analyses. As early as 24 hr following AdCre
treatment, anaphase bridges (41 out of 250 cells, 16%)
as well as multiple chromosome aberrations including
chromosomal fusions, breaks, and fragments (35 out of103 metaphases, 34%) were observed in all Pot1arec/D,
p53/MEF cell lines examined (Figure 7A). In sharp con-
trast, no anaphase bridges and minimal chromosome ab-
errations (4 out of 135 metaphases, 3%) were observed in
AdE-treated Pot1arec/D, p53/ MEFs. A similar low level
of aberrations was observed in AdCre-treated Pot1arec/+,
p53/ MEFs (anaphase bridge: 1 out of 250 cells,
0.4%; cytogenetic aberrations: 11 out of 138metaphases,
8%), indicating that the elevated number of chromosomal
aberrations resulted from loss of both Pot1a alleles. A
progressive increase in the number of fused chromo-
somes was observed in 100% of Pot1arec/D, p53/meta-
phases examined 48–96 hr following AdCre treatment.
Telomere PNA-FISH characterized these fusions eitherCell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc. 57
Figure 7. Pot1a Loss Leads to Multiple Cytogenetic Aberrations
(Aa–Ad) Anaphase bridge formation (arrowheads in [Aa] and [Ab]) and chromosomal fusionswith telomeres at the site of fusion (arrowheads in [Ac] and
[Ad]) in AdCre-treated Pot1arec/D, p53/ MEFs.
(B) Additional cytogenetic aberrations included q-q arm chromosomal fusions without telomeric signals at fusion sites (arrowheads in [Ba]), isochro-
matid ring chromosomes completely devoid of telomeres (arrowhead in [Bb]), isochromatid ring chromosome without telomeres at sites of fusion
(arrowhead in [Bc]); TDMs (Bd), chromosomal fragment without telomeres (arrowhead in [Be]), TDMs with all four telomeres (Bf), telomere fragments
containing leading and lagging telomeric DNA (Bg), lagging telomeric fragments (Bh), and isochromatid breaks (arrowheads in [Bi]).
(C) Quantitation of cytogenetic aberrations in the indicated genotypes. n = 221 metaphases scored. *p < 0.01, **p < 0.005 (Student’s t test).
(D) Focus-forming assay revealing that Pot1aD/D, p53/ cells efficiently formed immortalized foci.
(E) Only Pot1aD/D, p53/ foci (4 out of 4 clones) formed skin tumors within 4 weeks when injected subcutaneously into SCID mice.as possessing telomeric signals at the site of fusion (0.5
fusions per metaphase) or as being without telomeric sig-
nals (2.3 per metaphase; Figures 7A and 7C and Table S3).
Multiple novel isochromatid rings characteristic of Pot1a
loss were observed, resulting from sister-sister chromatid
q-q arm fusions (Figures 7B and 7C and Table S3). Finally,
a 7-fold increase in chromosome fragments was observed
followingPot1a deletion (Figures 7B and 7Cand Table S3).
Taken together, these results indicate that POT1a plays an
important role in mediating telomere end protection and
the maintenance of chromosomal stability.
In the setting of p53 deficiency, dysfunctional telomeres
provide a mechanism to generate genomic instability, re-
sulting in increased tumorigenesis (Artandi et al., 2000;58 Cell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc.Rudolph et al., 1999). To investigate whether the elevated
genomic instability following Pot1a loss can promote cel-
lular transformation, we subjected Pot1a-deficient MEFs
to a focus-forming assay. Compared to Pot1a+/+, p53/
and Pot1arec/D, p53/ controls, Pot1aD/D, p53/ fibro-
blasts exhibited an approximately 8-fold increase in the
number of transformed foci (Figure 7D). Four out of four
Pot1aD/D, p53/ subclones analyzed displayed hallmarks
of transformed cells, including rapid growth, proliferation
in a low-density seeding assay, and formation of soft-
tissue sarcomas within 4 weeks of subcutaneous injection
into SCIDmice (Figure 7E and data not shown), while 0 out
of 3 Pot1arec/D, p53/ foci displayed these characteris-
tics. Taken together, these data suggest that loss of
Pot1a can cooperate with p53 deficiency to enhance ma-
lignant transformation and tumor formation in vivo.
DISCUSSION
The data presented here indicate that POT1a is a single-
stranded telomere binding protein that plays an essential
role in mammalian telomere end protection and regulation
of telomere length. Our results suggest that POT1a is cru-
cial for the maintenance of telomere integrity and overall
genomic stability.
POT1a Represses HR at Telomeres
Telomeres can adopt a t-loop structure in which the 30 sin-
gle-stranded overhang is sequestered into internal duplex
telomeric repeats to protect it from degradation by exonu-
cleases (Griffith et al., 1999; Nikitina and Woodcock,
2004). However, a t-loop also resembles a Holliday junc-
tion (HJ), a structure characteristic of substrates undergo-
ing HR. The HR pathway appears to play an active role at
telomeres since the HR protein RAD51D associates with
telomeres and is required for proper telomere mainte-
nance (Tarsounas et al., 2004). HR between telomeres of
sister chromatids (T-SCE) can serve to lengthen the telo-
mere of one chromatid at the expense of the other, confer-
ring a proliferative advantage to cells that stochastically
acquire longer telomeres (Bailey et al., 2004; Laud et al.,
2005). HR could also take place between telomeres and
internal telomeric sequences, generating large chromo-
somal deletions containing telomeric DNA (TDMs) (Zhu
et al., 2003). In cells utilizing the alternative lengthening
of telomere (ALT) pathway tomaintain telomeres, elevated
T-SCE (Bechter et al., 2004; Londono-Vallejo et al., 2004)
and extrachromosomal telomere circles generated
through aberrant HR at telomeres (Cesare and Griffith,
2004; Wang et al., 2004) are prominent features. Taken
together, these data support a model in which telomeric
HR is vital for telomere length maintenance in the absence
of telomerase.
In normal cells, inappropriate HR at telomeres must be
repressed since branch migration of the 30 overhang in
a t-loop can create a HJ that can be cleaved by HJ resol-
vase to generate extrachromosomal telomeric circles,
leading to telomere shortening and premature entry into
senescence (Lustig, 2003; Wang et al., 2004). Overex-
pression of a truncated mutant TRF2 (TRF2DB) leads to
HR-dependent resection of telomeric DNA (t-loop HR),
suggesting that TRF2 normally represses telomere HR
(Wang et al., 2004). However, since Trf2 null MEFs do
not exhibit elevated t-loop HR (Celli and de Lange,
2005), its repression most likely requires other compo-
nents of the telosome complex. Our results suggest that
POT1a might play a prominent role in repressing inappro-
priate HR at telomeres. In Pot1a-deficient cells, multiple
chromosomal aberrations characteristic of aberrant telo-
mere HR were present, including telomeric circles,
TDMs, and T-SCEs. Formation of these aberrant cytoge-
netic structures is likely favored by the increase in the 30overhang length in Pot1a-deficient MEFs, enabling effi-
cient invasion of this single-stranded end into the homol-
ogous double-stranded DNA to generate a HJ. Depending
on where the recombination takes place, HJ resolution
could yield a large deletion (TDMs), extrachromosomal
telomere circles, or, if it takes place in trans, T-SCEs.
The resulting telomere may still possess a 30 overhang
but might not be able to reform a functional t-loop in the
absence of POT1a.
Our results also suggest that t-loop HR following Pot1a
deletion requires NBS1, a component of the MRN com-
plex. Although the MRN complex plays diverse roles in
DNA metabolism, recent data suggest that it plays a role
in mediating HR following DNA damage by removing nu-
cleosomes from DSBs, then recruiting RAD51 to the site
of DNA damage (Tsukuda et al., 2005). In mammalian
cells, the MRN complex localizes to telomeres in a cell-
cycle-dependent manner (Zhu et al., 2000) and may be
required for proper processing of telomeric ends, enabling
t-loop formation via a pathway resembling HR (Verdun
et al., 2005). Interestingly, t-loop HR also requires the
RAD51 paralog XRCC3 (Wang et al., 2004). Since recruit-
ment of theMRN complex to telomeres precedes the tran-
sient release of POT1 from telomeres, it is tempting to
speculate that loss of POT1a promotes MRN-mediated
recruitment of XRCC3 to telomeres for t-loop HR.
Lagging-Strand Telomere Replication
Requires POT1a
The recent demonstration that POT1 has the ability to re-
solve G quadruplexes in telomeric repeats (Zaug et al.,
2005), coupled with its physical association with the
WRN protein (Opresko et al., 2005), suggests a possible
role for POT1 in lagging-strand telomere replication.
WRN is a member of the RecQ helicase family and pos-
sesses the ability to resolve telomeric G quadruplexes
(Mohaghegh et al., 2001) as well as unwind telomeric D
loops in vitro (Opresko et al., 2004). Recent evidence indi-
cates that lagging-strand telomere synthesis is diminished
in the absence of WRN (Crabbe et al., 2004). Since POT1
cooperates with WRN to efficiently unwind telomeric sub-
strates in vitro (Opresko et al., 2005), it is likely that both
proteins are required to dissociate G quadruplexes at
the G-rich telomeric strand to facilitate replication fork
progression through this region. We postulate that loss
of Pot1a results in an inability to resolve stalled replication
forks in G-rich regions, resulting in DSBs and preferential
loss of lagging-strand telomeric DNA in affected Pot1aD/D
cells (Figure S4B). Other likely outcomes of this scenario
include fusion of resulting isochromatid breaks, formation
of sister union products, and telomeric fragments, all
prominent cytogenetic features following Pot1a loss
(Figure S4C).
Role of POT1a in Telomere End Protection
and Length Regulation
Our data suggest that POT1a is crucial for the formation
and maintenance of intact, functional mammalianCell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc. 59
telomeres. Deletion of Pot1a rendered telomeres accessi-
ble to exogenous factors such as the enzyme TdT, sug-
gesting that POT1a normally occludes the 30 end of telo-
meres, consistent with the in vitro data (Kelleher et al.,
2005). POT1 also appears to be involved in the control
of nucleolytic processing of the 50 C-rich strand (Hocke-
meyer et al., 2005). POT1a could protect telomeres from
NHEJ by promoting the formation of the t-loop and mod-
ulating the enzymatic machinery that generates the 30 G
tail. This notion is supported by our data demonstrating
that deletion of Pot1a leads to both telomere length and
30 overhang elongation. Since POT1a competes with telo-
merase for the 30 terminal G residue of telomeres, it is not
surprising that loss of POT1a promotes telomere elonga-
tion in mouse cells where telomerase is not limiting. We
speculate that the observed G overhang elongation fol-
lowing Pot1a deletionmay be due in part to the loss of reg-
ulation of 50 nucleolytic processing on the C-rich strand
from an as yet unidentified nuclease or nucleases, leading
to unregulated degradation of the C strand. This scenario
is analogous to the C strand protective role exerted by the
POT1 homolog Cdc13 (Garvik et al., 1995).
Pot1a Deletion Promotes Genomic Instability
Loss of Pot1a results in anaphase bridge formation, in-
creased chromosomal fusions, and the generation of di-
centric chromosomes. However, the number of chromo-
somal fusions in Pot1a-deficient cells was much more
modest than the number of fused chromosomes observed
following Trf2 deletion (Celli and de Lange, 2005). It is likely
that the increased 30 overhang length following Pot1a loss
rendered telomeres poor substrates for NHEJ-mediated
chromosomal fusions. In addition, POT1b may cooperate
with POT1a to exert some end-protective functions at
telomeres to reduce NHEJ-mediated chromosomal fu-
sions (H.H, A.S.M., W.C.-B., H.T., J. Ma, S.P., Y.D., and
S.C. unpublished data; Hockemeyer et al., 2006). What-
ever the mechanism, it appears that, in the absence of
p53, chromosomal aberrations stemming from Pot1a
loss can enhance cellular transformation and subsequent
tumor formation in mice. These results are further sup-
ported by the observation that downregulation of POT1
is observed in low-grade stage I/II human gastric carcino-
mas that are accompanied by telomere dysfunction and
anaphase bridge formation (Kondo et al., 2004). Taken
together, our data support a role for POT1a in protecting
telomeres from initiating inappropriate telomere-telomere
recombination events that are potentially genome desta-
bilizing and tumor promoting.
EXPERIMENTAL PROCEDURES
Generation of Conditional Pot1a Knockout Mice
A BAC encoding the entire Pot1a gene was isolated from a RPCI-22
129SvJ BAC genomic library (Children’s Hospital, Oakland Research
Institute). A long-range PCR strategy was used to obtain the correct
genomic fragments for generating the targeting construct. The Pot1a
targeting vector was generated by subcloning a 2.1 kb EcoRI-XhoI
fragment 50 of the first loxP site in the pKOII vector. A 10.1 kb SacII-60 Cell 126, 49–62, July 14, 2006 ª2006 Elsevier Inc.NotI fragment containing exons 4 and 5 was subcloned 30 of the neo
cassette, and a second loxP site was inserted 30 of exon 5. The vector
was linearized with NotI and electroporated into AB2.1 ES cells. ES
cells containing the correct recombination events were identified by
Southern analysis, and two clones were selected for injection into
C57BL/6 blastocysts. Chimeric mice were crossed with C57BL/6 ani-
mals to generate Pot1arec/+ mice. Pot1arec/+ mice were intercrossed
with CMV-Cre mice (Arango et al., 1999) to generate Pot1aD/+ mice.
Pot1arec/+ mice were bred with Pot1aD/+ mice to generate Pot1a+/+,
Pot1arec/D, and Pot1arec/+ embryos for the production of MEFs. Inter-
crosses with p53/ mice were performed to obtain Pot1a conditional
alleles in a p53/ background. All miceweremaintained in aC57BL/6/
129Sv mixed genetic background.
Conditional Deletion of Pot1a
Pot1a+/+, Pot1arec/D, and Pot1arec/+ MEFs were prepared from individ-
ual day 13.5 embryos as described (Blasco et al., 1997) and cultured in
DMEM with 10% serum under 3% O2 to prevent culture-induced se-
nescence (Parrinello et al., 2003). To delete the conditional Pot1a al-
lele, passage 1-3 Pot1arec/D and Pot1arec/+ MEFs were infected with
AdCre at a moi of 100. Deletion of Pot1a was confirmed by RT-PCR
and Western analyses.
CO-FISH Analysis for T-SCEs and Telomere Loss
CO-FISH was performed as described (Bailey et al., 2001). Hybridiza-
tion ofmetaphase spreadswas performedwith TRITC-OO-(TTAGGG)4
or FITC-OO-(CCCTAA)4 peptide nucleic-acid probes (Applied Biosys-
tems). For simultaneous visualization of both leading and lagging
strands, both probes were used at a concentration of 0.5 mg/ml. For
CO-FISH, a minimum of 700 chromosome ends were scored blindly
for each genotype, and pairwise comparisons for statistical signifi-
cance were made by Student’s t test. Scoring for telomere loss was
conducted in separate FITC and rhodamine channels on a minimum
of 2500 chromosome ends. Differences between genetic backgrounds
were considered significant only when p values were less than 0.01.
Images were captured and processed with MetaMorph Premier (Mo-
lecular Devices).
2D Gel Electrophoresis to Detect Telomere Circles
Neutral-neutral 2D gel electrophoresis was performed as described
(Wang et al., 2004). Briefly, 20 mg of genomic DNAs was resolved in
the first dimension in a 0.4% agarose gel at 1V/cm, stained, and
then cut out and cast into a second 1.1% agarose gel at a 90º orienta-
tion from the first gel and resolved at 5V/cm. The gel was denatured
and neutralized, and in-gel hybridization was performed using a
(TTAGGG)4 probe to detect telomeric circles and total telomeres. For
comigration analysis of circularized l X HindIII with telomere circles,
genomic DNA and circularized l X HindIII DNAs were fractionated to-
gether, and the gel was probed for l DNA, stripped, and subsequently
reprobed with telomeric oligos. Gel images were individually acquired,
processed, and merged in Adobe Photoshop CS.
Additional technical information is described in the Supplemental
Experimental Procedures.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, four figures, and three tables and can be
found with this article online at http://www.cell.com/cgi/content/full/
126/1/49/DC1/.
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